Yu Xu

Yu Xu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Ophthalmology
Verified
Journal Article
Closed access
QHQiujing Huang
Qiujing Huang
QZQi Zhang
Qi Zhang
PFPing Fei
Ping Fei
YXYu Xu
Yu Xu
JLJiao Lyu
Jiao Lyu
PZPeiquan Zhao
Peiquan Zhao

4 December 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
HCHan Chen
Han Chen
ECEnguang Chen
Enguang Chen
TCTing Cao
Ting Cao
FFFeifan Feng
Feifan Feng
MLMin Lin
Min Lin
YXYu Xu
Yu Xu
Background: Diabetic retinopathy (DR) is a major complication of diabetes, leading to severe vision impairment. Understanding the molecular mechanisms, particularly PANoptosis, underlying DR is crucial for identifying potential biomarkers and therapeutic targets. This study aims to identify differentially expressed PANoptosis-related genes (DE-PRGs) in DR, offering insights into the disease’s pathogenesis and potential diagnostic tools.Methods: DR datasets were obtained from the Gene Expression Omnibus (GEO) database, while PANoptosis-related genes were sourced from the GeneCards database. Differentially expressed genes (DEGs) were identified using the DESeq2 package, followed by functional enrichment analysis through DAVID and Metascape tools. Three machine learning algorithms—LASSO regression, Random Forest, and SVM-RFE—were employed to identify hub genes. A diagnostic nomogram was constructed and its performance assessed via ROC analysis. The CIBERSORT algorithm analyzed immune cell infiltration. Hub genes were validated through RT-qPCR, Western blotting, immunohistochemistry, and publicly available datasets. Additionally, the impact of FASN and PLSCR3 knockdown on HUVECs behavior was validated through in vitro experiments.Results: Differential expression analysis identified 1,418 DEGs in the GSE221521 dataset, with 39 overlapping DE-PRGs (29 upregulated, 10 downregulated). Functional enrichment indicated that DE-PRGs are involved in apoptosis, signal transduction, and inflammatory responses, with key pathways such as MAPK and TNF signaling. Machine learning algorithms identified six PANoptosis-related hub genes (BEX2, CASP2, CD36, FASN, OSMR, and PLSCR3) as potential biomarkers. A diagnostic nomogram based on these hub genes showed high diagnostic accuracy. Immune cell infiltration analysis revealed significant differences in immune cell patterns between control and DR groups, especially in Activated CD4 Memory T Cells and Monocytes. Validation confirmed the diagnostic efficiency and expression patterns of the PANoptosis-related hub genes, supported by in vitro and the GSE60436 dataset analysis. Furthermore, experiments demonstrated that knocking down FASN and PLSCR3 impacted HUVECs behavior.Conclusion: This study provides valuable insights into the molecular mechanisms of DR, particularly highlighting PANoptosis-related pathways, and identifies potential biomarkers and therapeutic targets for the disease.

11 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JSJesse D. Sengillo
Jesse D. Sengillo
TCThiago Cabral
Thiago Cabral
KSKaspar Schuerch
Kaspar Schuerch
JDJimmy Duong
Jimmy Duong
WLWinston Lee
Winston Lee
STStephen Tsang
Stephen Tsang
Usher syndrome is an inherited and irreversible disease that manifests as retinitis pigmentosa (RP) and bilateral neurosensory hearing loss. Mutations in Usherin 2A (USH2A) are not only a frequent cause of Usher syndrome, but also nonsyndromic RP. Although gene- and cell-based therapies are on the horizon for RP and Usher syndrome, studies characterizing natural disease are lacking. In this retrospective analysis, retinal function of USH2A patients was quantified with electroretinography. Both groups had markedly reduced rod and cone responses, but nonsyndromic USH2A patients had 30 Hz-flicker electroretinogram amplitudes that were significantly higher than syndromic patients, suggesting superior residual cone function. There was a tendency for Usher syndrome patients to have a higher distribution of severe mutations, and alleles in this group had a higher odds of containing nonsense or frame-shift mutations. These data suggest that the previously reported severe visual phenotype seen in syndromic USH2A patients could relate to a greater extent of cone dysfunction. Additionally, a genetic threshold may exist where mutation burden relates to visual phenotype and the presence of hearing deficits. The auditory phenotype and allelic hierarchy observed among patients should be considered in prospective studies of disease progression and during enrollment for future clinical trials.

1 January 2021 in International Journal of Medical Sciences
Verified
Journal Article
Open access
YZYedi Zhou
Yedi Zhou
YXYu Xu
Yu Xu
XZXiang zhang
Xiang zhang
QHQian Huang
Qian Huang
WTWei Tan
Wei Tan
YLYun Li
Yun Li
Background: Retinopathy of prematurity (ROP) is a retinal disease that causes blindness in premature infants. This study aimed to reveal the changes in amino acids and derivatives in the plasma of ROP patients compared with premature infants without ROP.

26 April 2022 in The FASEB Journal
Verified
Journal Article
Closed access
JWJianhui Wang
Jianhui Wang
QZQi Zhang
Qi Zhang
ECEnguang Chen
Enguang Chen
PZPeiquan Zhao
Peiquan Zhao
YXYu Xu
Yu Xu

15 November 2010 in Endocrine
Verified
Journal Article
Closed access
PDF file
YXYu Xu
Yu Xu
ZZZhiyun Zhao
Zhiyun Zhao
XLXiaoying Li
Xiaoying Li
YBYufang Bi
Yufang Bi
Min XuMin Xu
Min Xu
GNGuang Ning
Guang Ning